Pini, L.; Bagnasco, D.; Beghè, B.; Braido, F.; Cameli, P.; Caminati, M.; Caruso, C.; Crimi, C.; Guarnieri, G.; Latorre, M.;
et al. Unlocking the Long-Term Effectiveness of Benralizumab in Severe Eosinophilic Asthma: A Three-Year Real-Life Study. J. Clin. Med. 2024, 13, 3013.
https://doi.org/10.3390/jcm13103013
AMA Style
Pini L, Bagnasco D, Beghè B, Braido F, Cameli P, Caminati M, Caruso C, Crimi C, Guarnieri G, Latorre M,
et al. Unlocking the Long-Term Effectiveness of Benralizumab in Severe Eosinophilic Asthma: A Three-Year Real-Life Study. Journal of Clinical Medicine. 2024; 13(10):3013.
https://doi.org/10.3390/jcm13103013
Chicago/Turabian Style
Pini, Laura, Diego Bagnasco, Bianca Beghè, Fulvio Braido, Paolo Cameli, Marco Caminati, Cristiano Caruso, Claudia Crimi, Gabriella Guarnieri, Manuela Latorre,
and et al. 2024. "Unlocking the Long-Term Effectiveness of Benralizumab in Severe Eosinophilic Asthma: A Three-Year Real-Life Study" Journal of Clinical Medicine 13, no. 10: 3013.
https://doi.org/10.3390/jcm13103013
APA Style
Pini, L., Bagnasco, D., Beghè, B., Braido, F., Cameli, P., Caminati, M., Caruso, C., Crimi, C., Guarnieri, G., Latorre, M., Menzella, F., Micheletto, C., Vianello, A., Visca, D., Bondi, B., El Masri, Y., Giordani, J., Mastrototaro, A., Maule, M.,
... on behalf of the SANI Study Group.
(2024). Unlocking the Long-Term Effectiveness of Benralizumab in Severe Eosinophilic Asthma: A Three-Year Real-Life Study. Journal of Clinical Medicine, 13(10), 3013.
https://doi.org/10.3390/jcm13103013